Diuretic response to adenosine A1 receptor blockade in normotensive and spontaneously hypertensive rats: Role of pertussis toxin-sensitive G-proteins

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 2, 2000, Pages 752-760

  Kost Jr , Curtis K ^a,b   Herzer, William A ^a   Rominski, Barbara R ^a   Mi, Zaichuan ^a   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR ANTAGONIST; DIURETIC AGENT; FUROSEMIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; HALOTHANE; PERTUSSIS TOXIN;

ANIMAL MODEL; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DIURESIS; DIURETIC THERAPY; DRUG EFFECT; HYPERTENSION; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; BLOOD PRESSURE; DIURESIS; DRUG INTERACTIONS; FUROSEMIDE; GTP-BINDING PROTEINS; HYPERTENSION; MALE; NATRIURESIS; PERTUSSIS TOXIN; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; VIRULENCE FACTORS, BORDETELLA; XANTHINES;

EID: 0342614949     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Albino-Teixeira A, Matias A, Polonia J and Azevedo I (1991) Blockade of adenosine receptors causes hypertension and cardiovascular structural changes in the rat. J Hypertens 9:S196-S197.
2. 1-mediated hemodynamic effects. J Pharmacol Exp Ther 268:1506-1511.
3. Choi KC, Lee J, Moon KH, Park KK, Kim SW and Kim NH (1993) Chronic caffeine ingestion exacerbates 2-kidney, 1-clip hypertension and ameliorates deoxycortico-sterone acetate-salt hypertension in rats. Nephron 65:619-622.
4. 1-adenosine receptor antagonist. J Pharm Pharmacol 43:138-139.
5. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P and Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
6. Gellai M, Schreiner GF, Ruffolo RR Jr, Fletcher T, Dewolf R and Brooks DP (1998) CVT-124, a novel adenosine Al receptor antagonist with unique diuretic activity. J Pharmacol Exp Ther 286:1191-1196.
7. 2+]-dependent mechanism. Kidney Int 47:1676-1584.
8. Jackson EK (1997) Renal actions of purines, in Purinergic Approaches in Experimental Therapeutics (Jacobson KA and Jarvis MF eds) pp 217-250, Wiley-Liss, New York.
9. Kawabata M, Ogawa T and Takabatake T (1998) Control of rat glomerular microcirculation by juxtaglomerular adenosine A1 receptors. Kidney Int 54 (Suppl 67):S228-S230.
10. 1-adenosine receptor antagonist. Br J Pharmacol 109:271-277.
11. Kohno M, Murakawa K, Horio T, Yokokawa K, Yasunari K, Fukui T and Takeda T (1991) Plasma immunoreactive endothelin-1 in experimental malignant hypertension. Hypertension 18:93-100.
12. Komatsu M, McDermott AM, Gillison SL and Sharp GWG (1995) Time course of action of pertussis toxin to block the inhibition of stimulated insulin release by norepinephrine. Endocrinology 136:1857-1863.
13. Kost CK Jr, Herzer WA, Li PJ and Jackson EK (1999) Pertussis toxin-sensitive G-proteins and regulation of blood pressure in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 26:449-455.
14. Kost CK Jr, Herzer WA, Mi Z and Jackson EK (1998) Diuretic/natriuretic response to A1-receptor blockade in normotensive and hypertensive rats: Role of Gi-proteins. J Am Soc Nephrol 9:310A.
15. Kost CK Jr, Li P, Pfeifer CA and Jackson EK (1994) Telemetric blood pressure monitoring in benign 2-kidney, 1-clip renovascular hypertension: Effect of chronic caffeine ingestion. J Pharmacol Exp Ther 270:1063-1070.
16. Kuan CJ, Herzer WA and Jackson EK (1992) An experimental paradigm for investigating the role of endogenous adenosine/A1 receptor interactions in vivo. J Pharmacol Exp Ther 263:657-662.
17. 1 adenosine receptors. J Cardiovasc Pharmacol 21:822-828.
18. Matias A, Albino-Teixeira A, Polonia J and Azevedo I (1991) Long-term administration of 1,3-dipropyl-8-sulfophenylxanthine causes arterial hypertension. Eur J Phamacol 193:101-104.
19. 1-receptor antagonist, via pertussis toxin insensitive mechanism. J Pharmacol Exp Ther 266:200-206.
20. 1-receptor blockade on glomerular hemodynamics: Involvement of renin-angiotensin system. Am J Physiol 267:F783-F790.
21. Murray RD and Churchill PC (1984) Effects of adenosine receptor agonists in the isolated, perfused rat kidney. Am J Physiol 247:H343-H348.
22. 1-receptor antagonist, in Dahl salt-sensitive rats. Jpn J Pharmacol 68:389-396.
23. Ohnishi A, Biaggioni I, Deray G, Branch RA and Jackson EK (1986a) Hemodynamic effects of adenosine in conscious hypertensive and normotensive rats. Hypertension 8:391-398.
24. Ohnishi A, Branch RA, Jackson K, Hamilton R, Biaggioni I, Deray G and Jackson EK (1986b) Chronic caffeine administration exacerbates renovascular, but not genetic, hypertension in rats. J Clin Invest 78:1045-1050.
25. Ohnishi A, Li P, Branch RA, Biaggioni IO and Jackson EK (1988) Adenosine in renin-dependent renovascular hypertension. Hypertension 12:152-161.
26. Osswald H, Hermes HH and Nabakowski G (1982) Role of adenosine in signal transmission of tubuloglomerular feedback. Kidney Int 22 (Suppl 12):S136-S142.
27. Osswald H, Spielman WS and Knox FG (1978) Mechanism of adenosine-mediated decreases in glomerular filtration rate in dogs. Circ Res 43:465-469.
28. Rubino A and Burnstock G (1995) Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8-sulfophenylxanthine-induced hypertension. J Pharmacol Exp Ther 275:422-428.
29. Spielman WS and Thompson CI (1982) A proposed role for adenosine in the regulation of renal hemodynamics and renin release. Am J Physiol 242:F423-F435.
30. 1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure. J Med Chem 35:3066-3075.
31. 1 receptor. Am J Physiol 265:F511-F519.
32. Uehara Y, Numabe A, Hirawa N, Kawabata Y, Nagoshi H, Kaneko H, Gomi T, Goto A, Toyo-Oka T and Omata M (1995) A new adenosine subtype-1 receptor antagonist, FK-838, attenuates salt-induced hypertension in Dahl salt-sensitive rats. Am J Hypertens 8:1189-1199.
33. van Buren M, Bijlsma JA, Boer P, van Rijn HJM and Koomans HA (1993) Natriuretic and hypotensive effect of adenosine-1 blockade in essential hypertension. Hypertension 22:728-734.
34. Wilcox CS, Welch WJ, Schreiner GF and Belardinelli L (1999) Natriuretic and diuretic actions of a highly selective adenosine A1 receptor antagonist. J Am Soc Nephrol 10:714-720.
35. Zou AP, Nithipatikom K, Li PL and Cowley AW Jr (1999) Role of renal medullary adenosine in the control of blood flow and sodium excretion. Am J Physiol 276: R790-R798.